EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesenchymal Stem Cell Membrane‐Camouflaged Liposomes for Biomimetic Delivery of Cyclosporine A for Hepatic Ischemia‐Reperfusion Injury Prevention

Haitian Chen, Wen Yin, Kang Yao, Jinliang Liang, Jianye Cai, Xin Sui, Xuegang Zhao, Jiebin Zhang, Jiaqi Xiao, Rong Li, Qiuli Liu, Jia Yao und 11 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202404171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Haitian Chen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic Surgery and Liver Transplantation Center of The Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen Univers…. Hauptthemen laut MEDLINE: Cyclosporine, Reperfusion Injury, Liposomes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Research Grants Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic ischemia‐reperfusion injury (HIRI) is a prevalent issue during liver resection and transplantation, with currently no cure or FDA‐approved therapy. A promising drug, Cyclosporin A (CsA), ameliorates HIRI by maintaining mitochondrial homeostasis but has systemic side effects due to its low bioavailability and high dosage requirements. This study introduces a biomimetic CsA delivery system that directly targets hepatic lesions using mesenchymal stem cell (MSC) membrane‐camouflaged liposomes. These hybrid nanovesicles (NVs), leveraging MSC‐derived proteins, demonstrate efficient inflammatory chemotaxis, transendothelial migration, and drug‐loading capacity. In a HIRI mouse model, the biomimetic NVs accumulated at liver injury sites entered hepatocytes, and significantly reduced liver damage and restore function using only one‐tenth of the CsA dose typically required. Proteomic analysis verifies the protection mechanism, which includes reactive oxygen species inhibition, preservation of mitochondrial integrity, and reduced cellular apoptosis, suggesting potential for this biomimetic strategy in HIRI intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclosporineReperfusion InjuryLiposomesMesenchymal Stem CellsDisease Models, AnimalAnimalsMiceBiomimeticsLiverDrug Delivery SystemsMaleMice, Inbred C57BL

Stichwörter der Autor:innen

biomimetic deliverycyclosporine Aischemia‐reperfusion injurymesenchymal stem cell

Substanzen

CyclosporineLiposomes

Autor:innen und Institutionen

  • Department of Hepatic Surgery and Liver Transplantation Center of The Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guan…
  • Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China.
  • Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, 999077, China.
  • Guangdong province engineering laboratory for transplantation medicine, Guangzhou, China.
  • Surgical ICU, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.

ORCID-Profile: Zong Dai

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Research Grants Council
  • Hong Kong General Research Fund
  • Hong Kong Polytechnic University Postdoctoral Fellowship Fund
  • Science and Technology Program of Guangdong Province
  • Natural Science Foundation of Guangdong Province
  • Science and Technology Program of Guangzhou

Zitieren

APA

Chen, H., Yin, W., Yao, K., Liang, J., Cai, J., Sui, X., Zhao, X., Zhang, J., Xiao, J., Li, R., Liu, Q., Yao, J., You, G., Liu, Y., Jiang, C., Qiu, X., Wang, T., You, Q., Zhang, Y., …, & Yang, Y. (2024). Mesenchymal Stem Cell Membrane‐Camouflaged Liposomes for Biomimetic Delivery of Cyclosporine A for Hepatic Ischemia‐Reperfusion Injury Prevention. Advanced Science. https://doi.org/10.1002/advs.202404171

Vancouver

Chen H, Yin W, Yao K, Liang J, Cai J, Sui X, et al. Mesenchymal Stem Cell Membrane‐Camouflaged Liposomes for Biomimetic Delivery of Cyclosporine A for Hepatic Ischemia‐Reperfusion Injury Prevention. Advanced Science. 2024. doi:10.1002/advs.202404171

BibTeX
@article{Chen2024,
  author = {Chen, Haitian and Yin, Wen and Yao, Kang and Liang, Jinliang and Cai, Jianye and Sui, Xin and Zhao, Xuegang and Zhang, Jiebin and Xiao, Jiaqi and Li, Rong and Liu, Qiuli and Yao, Jia and You, Guohua and Liu, Yasong and Jiang, Chenhao and Qiu, Xiaotong and Wang, Tingting and You, Qiang and Zhang, Yingcai and Yang, Mo and Zheng, Jun and Dai, Zong and Yang, Yang},
  title = {Mesenchymal Stem Cell Membrane‐Camouflaged Liposomes for Biomimetic Delivery of Cyclosporine A for Hepatic Ischemia‐Reperfusion Injury Prevention},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202404171}
}
Kostenlos starten →